BeiGene Ltd BGNE global phase 3 study RATIONALE 305 reached its primary endpoint overall survival with tislelizumab in combination with chemotherapy in patients with
Merck & Co Inc MRK announced results from the pivotal Phase 3 KEYNOTE-859 study of Keytruda (pembrolizumab) with fluoropyrimidine and platinum-based chemotherapy for gastric cancer.
The proportion of cancer-related deaths worldwide has increased significantly in recent years. The World Health Organization (WHO) estimates that more than 8 million people die
SYDNEY, Australia and FLORHAM PARK, NJ, November 10, 2022 (GLOBE NEWSWIRE) — Imugene Limited IMUa clinical-stage immuno-oncology company, and Celularity Inc. CELU (Celularity), a clinical-stage
NEW YORK and SHANGHAI, Sept. 28, 2022 (GLOBE NEWSWIRE) — TH International Limited, the exclusive operator of Tim Hortons coffee shops in China (“Tims China”
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents
Under Florida’s no-fault system, your PIP pays medical bills (typically 80%) and lost wages (about 60%) after a crash, regardless of fault, but prompt action is crucial. Get treatment within
injuredly News Provide the latest news. All News World News, Business News, Health Care, Life Style. All News Around the World Update On This Website.